Cancer Treatment Reviews
Volume 37, Issue 2 , Pages 97-104, April 2011

Which factors should be taken into account in perimenopausal women with early breast cancer who may become eligible for an aromatase inhibitor? Recommendations of an expert panel

  • O. Ortmann

      Affiliations

    • Department of Gynaecology and Obstetrics, University of Regensburg, Germany
    • Corresponding Author InformationCorresponding author. Address: Department of Gynaecology and Obstetrics, University of Regensburg, Landshuter Strasse 65, D-93053 Regensburg, Germany. Tel.: +49 941 782 7511; fax: +49 941 782 7515.
    • ,
  • O. Pagani

      Affiliations

    • Institute of Oncology of Southern Switzerland, Bellinzona, Switzerland
    • ,
  • A. Jones

      Affiliations

    • Department of Clinical Oncology, Royal Free Hospital, London, UK
    • ,
  • N. Maass

      Affiliations

    • University Clinic for Gynaecology and Obstetrics, Aachen, Germany
    • ,
  • D. Noss

      Affiliations

    • Department of Gynaecology and Obstetrics, University of Regensburg, Germany
    • ,
  • H. Rugo

      Affiliations

    • University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA
    • ,
  • C. van de Velde

      Affiliations

    • Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands
    • ,
  • Matti Aapro

      Affiliations

    • Clinique de Genolier, Genolier, Switzerland
    • ,
  • R. Coleman

      Affiliations

    • Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK

Received 24 March 2010; received in revised form 21 May 2010; accepted 25 May 2010. published online 01 July 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(10)00104-0

doi:10.1016/j.ctrv.2010.05.005

Cancer Treatment Reviews
Volume 37, Issue 2 , Pages 97-104, April 2011

Article Tools

* Image Usage & Resolution